The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in Singapore
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in Singapore ; volume:9 ; number:1 ; day:25 ; month:6 ; year:2019 ; pages:1-6 ; date:12.2019
Scientific reports ; 9, Heft 1 (25.6.2019), 1-6, 12.2019
- Urheber
-
Wu, Jonathan
Lim, Ee-Chien
Nadkarni, Nivedita V.
Tan, Eng-King
Kumar, Prakash M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-45110-5
- URN
-
urn:nbn:de:101:1-2019091113354466931253
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wu, Jonathan
- Lim, Ee-Chien
- Nadkarni, Nivedita V.
- Tan, Eng-King
- Kumar, Prakash M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Non-invasive, continuous oral delivery of solid levodopa-carbidopa for management of Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Non-invasive, continuous oral delivery of solid levodopa-carbidopa for management of Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment